Berberine: what the evidence actually shows

evidence catching-up berberine — 'nature's Ozempic' hype, but the glucose evidence is real and growing

Reviewer and governance status are shown on each atomic claim below.

What it is

Berberine is tracked as a health intervention in this evidence graph. No additional aliases are recorded.

Studied forms and doses

No form-specific catalog record is available. This does not mean all forms are equivalent.

blood sugar: 500 mg ×3/day; form not reported.
heart health: commonly 0.9–1.5 g/day; form not reported.
inflammation: varies across trials; form not reported.

Mechanisms

Mechanistic plausibility is context, not proof that a clinical outcome improves.

No structured mechanism is recorded.

⚠ Safety in context

moderatewith Metformin: Berberine also lowers glucose; combined with metformin it can compound hypoglycemia. Monitor with your clinician.

Products and verification

No product label snapshot is mapped in this released catalog. Ingredient evidence does not establish any bottle’s identity, potency, purity, availability, or value.

Evidence by outcome

blood sugargrade Bmoderate certainty— lowers fasting glucose and HbA1c; GI side effects common

heart healthgrade Bmoderate certainty— Meta-analysis of RCTs: berberine improved several cardiovascular risk factors — lowering total and LDL cholesterol, triglycerides, and blood pressure — versus control. It is a risk-factor signal, not a demonstrated reduction in cardiovascular events.

inflammationgrade Bmoderate certainty— Meta-analysis of 5 RCTs: berberine supplementation significantly decreased serum C-reactive protein versus control, with no significant heterogeneity between studies. The authors note patients with cardiovascular disease and diabetes may be the groups most likely to benefit; larger confirmatory trials are still needed.

People say · Evidence shows

“Berberine is nature's Ozempic”

aheadlargemarketing claim

Grade history

2026-07-16B → BCorrection by Claude Sonnet 5 (fabrication audit): live Postgres source drift replaced with the verified seed source set [pmid:36313096]. details →
2026-07-16B → BMerged additional source by Claude (gold-standard provenance sweep): a distinct, independently-verified paper ("The Effect of Berberine on M details →
2026-07-16B → BCorrection by Claude (gold-standard provenance sweep): live Postgres source drift replaced with the verified seed source set [pmid-38016844] details →
2026-05-10C → BNew meta-analysis strengthened the glycemic-control evidence. details →

Re-review cadence: every 12 months (Grade A/B) · next scheduled by 2027-07-16 · methodology v1.

By outcome — the money pages

Compare

sources: PMID:38016844 · PMID:34956436 · PMID:36313096 · PMID:31519292

Cite this page

Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.

Plain-text citation

Substrate. Berberine: what the evidence actually shows. https://evidencebased.info/interventions/berberine. Updated 2026-07-16.

BibTeX

@misc{substrate_terventionsberberine,
  author = {Substrate editorial},
  title  = {Berberine: what the evidence actually shows},
  year   = {2026},
  url    = {https://evidencebased.info/interventions/berberine},
  note   = {evidencebased.info}
}